← Back to Search

Dietary Supplement

Yeast Fermentate (EpiCor) for Immune Surveillance

N/A
Waitlist Available
Led By Gitte Jensen, PhD
Research Sponsored by Cargill
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at 1, 2, and 3 hours
Awards & highlights

Study Summary

This trial tests the effects of a nutraceutical on 30 healthy adults, to see if it can improve their immune system.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at 1, 2, and 3 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and at 1, 2, and 3 hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Immune Surveillance
Secondary outcome measures
Immune Communication
Other outcome measures
Immune Responsiveness

Trial Design

2Treatment groups
Experimental Treatment
Group I: Placebo intervention first and Active intervention one week laterExperimental Treatment1 Intervention
Participants will be consuming a placebo on a clinic day at least one week prior to a clinic day where they will consume the active intervention.
Group II: Active intervention first and Placebo intervention one week laterExperimental Treatment1 Intervention
Participants will be consuming active intervention on a clinic day at least 1 week prior to a clinic day where they will consume the placebo.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Yeast Fermentate (EpiCor)
2023
N/A
~30

Find a Location

Who is running the clinical trial?

Natural Immune Systems IncOTHER
18 Previous Clinical Trials
457 Total Patients Enrolled
2 Trials studying Immune Surveillance
48 Patients Enrolled for Immune Surveillance
CargillLead Sponsor
26 Previous Clinical Trials
3,159 Total Patients Enrolled
Gitte Jensen, PhDPrincipal InvestigatorNIS Labs
4 Previous Clinical Trials
96 Total Patients Enrolled

Media Library

Yeast Fermentate (EpiCor) (Dietary Supplement) Clinical Trial Eligibility Overview. Trial Name: NCT05819424 — N/A
Immune Surveillance Research Study Groups: Placebo intervention first and Active intervention one week later, Active intervention first and Placebo intervention one week later
Immune Surveillance Clinical Trial 2023: Yeast Fermentate (EpiCor) Highlights & Side Effects. Trial Name: NCT05819424 — N/A
Yeast Fermentate (EpiCor) (Dietary Supplement) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05819424 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants can sign up for this trial at its fullest capacity?

"Affirmative. Clinicaltrials.gov illustrates that the clinical trial is actively seeking participants, having been initially posted on May 16th 2023 and last modified on May 23rd 2023. 30 patients are needed for study at one medical centre."

Answered by AI

What qualifications are required for potential participants in this experiment?

"Under the requisite criteria of immune surveillance and an age range between 18 to 60 years old, this clinical trial will be accepting up to 30 participants."

Answered by AI

Is this experiment actively searching for participants at the moment?

"Clinicaltrials.gov reveals that this clinical trial is actively seeking participants, with the first posting having taken place on May 16th 2023 and last updated on May 23rd 2023."

Answered by AI

Is the age range for this research study inclusive of individuals past 35 years old?

"This medical study is recruiting individuals between the ages of 18 and 60."

Answered by AI
~16 spots leftby Apr 2025